Market capitalization | $870.00k |
Enterprise Value | $157.68m |
P/E (TTM) P/E ratio | negative |
EV/Sales (TTM) EV/Sales | 2.13 |
P/S ratio (TTM) P/S ratio | 0.01 |
P/B ratio (TTM) P/B ratio | negative |
Revenue growth (TTM) Revenue growth | -7.66% |
Revenue (TTM) Revenue | $73.95m |
EBIT (operating result TTM) EBIT | $-26.78m |
As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.
1 Analyst has issued a forecast Greenbrook TMS Inc:
1 Analyst has issued a forecast Greenbrook TMS Inc:
Jun '24 |
+/-
%
|
||
Revenue | 74 74 |
8%
8%
|
|
Gross Profit | -3.69 -3.69 |
124%
124%
|
|
EBITDA | - - |
-
|
EBIT (Operating Income) EBIT | -27 -27 |
10%
10%
|
Net Profit | -54 -54 |
21%
21%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Greenbrook Tms, Inc. engages in the provision of transcranial magnetic stimulation, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. The company was founded on February 9, 2018 and is headquartered in Toronto, Canada.
Head office | Canada |
CEO | William Leonard |
Employees | 489 |
Founded | 2018 |
Website | www.greenbrooktms.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.